| Norris Medicines Limited was established as a private limited company in the state of Maharashtra on 7th September 1990. The company commenced commercial operations in November 1991 with the commissioning of the formulations unit. The unit was set up at a total capacity outlay of Rs 135.85 lakhs, which was financed by equity contribution from the promoters and associates to the extent of Rs 108.12 lakhs and term loan of Rs 27.73 lakhs from Gujarat State Finance Corporation. Norris was converted into a public limited company with effect from 7th March 1992. 1990 Launch of Norris 1992 Launch of Ethical Division and conversion of company into Public Limited company 1994 WHO cGMP Certificate 1995 Major Expansions 1996 Started exporting to European, Middle East, Far East and African Countries 2000 The Company has decided to issue 1,80,00,000 No. of equity shares of Rs. 10 each on preferential/private placement basis at a price not less than Rs. 10 per share to PHC Holdings Ltd., 90,00,000 shares and Positive Healthcare (Asia) Ltd. 2006 -Launching of Diabetic & Cardiac products 2007 - Launching of Dental product range 2012 -Launching of New Molecule Tolperisone with Paracetamol tablet 2013 -Extension in Anti malarial range with Artemether Lumefantrine tablet & dry syrup |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article